| |
| Top Ten Securities as of 6/30/08 |
|
Wesco Intl. |
4.2% |
|
Novartis ADR |
3.7% |
|
Maxim Integrated Products |
3.5% |
|
Medtronic |
3.2% |
|
Lowe's |
3.2% |
|
Microsoft |
3.1% |
|
Boston Scientific |
3.1% |
|
Thermo Fisher Scientific |
3.0% |
|
Aflac |
2.9% |
|
Netapp |
2.8% |
| |
Securities listed are held in the account of a client that Roxbury believes to be representative of the Strategic Growth accounts it manages for various managed account or wrap fee programs sponsored by unrelated financial firms. Other clients of Roxbury managed by a different portfolio manager or with different investment objectives may hold different securities than those listed or may have sold some of these securities. Top 10 holdings listed should not be considered a recommendation to purchase or sell any particular security. The reader should not assume that tinvestments in the specific securities identified above were or will be profitable. Information provided for supplemental purposes only.
